EcoDrugPlus

Phosphodiesterase 3b

Ensembl ID : ENSBSLG00000014387
Gene Symbol: PDE3B
3 Cross references
204 Possible Orthologues:

Phosphodiesterase 4a

Ensembl ID : ENSBSLG00000018235
Gene Symbol: PDE4A
3 Cross references
187 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSBSLG00000020398
Gene Symbol: PDE4B
3 Cross references
226 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSBSLG00000009617
Gene Symbol: PDE4D
3 Cross references
222 Possible Orthologues:

Phosphodiesterase 5a

Ensembl ID : ENSBSLG00000010390
Gene Symbol: PDE5A
3 Cross references
209 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSBSLG00000022441
Gene Symbol: PDE7A
3 Cross references
215 Possible Orthologues:

Phosphodiesterase 7b

Ensembl ID : ENSBSLG00000022578
Gene Symbol: PDE7B
3 Cross references
174 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 1

Ensembl ID : ENSBSLG00000003181
Gene Symbol: PIK3R1
3 Cross references
203 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSBSLG00000013563
Gene Symbol: PIK3R3
3 Cross references
188 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSBSLG00000004902
Gene Symbol: PIK3R3
3 Cross references
199 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSBSLG00000007699
Gene Symbol: PIK3R5
3 Cross references
184 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSBSLG00000011605
Gene Symbol: PIK3R5
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).